Skip to main content
. 2015 Dec 27;2016:9701574. doi: 10.1155/2016/9701574

Figure 3.

Figure 3

Disease-free survival (DFS) rates according to the preoperative serum interleukin-6 (IL-6) status. (a) DFS of all 207 patients who underwent curative resection. (b) DFS of 188 patients with stages I–III colorectal cancer. (c) DFS of the 60 stage II patients.